SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: doctor bob who wrote (337)4/1/1998 2:59:00 AM
From: Jon Smith   of 1185
 
I realize I haven't been a part of this thread for very long, but I would like to offer my opinion. Reading through past news, it seems that NRT's style is to sign a deal, (licensing or otherwise) with the stipulation that the (purchaser) also makes an equity investment into the company. As they did when they signed with the Asian Pharma.

Therefore, I would expect to see a major licensing agreement followed by an equity financing or a positioning from the open market by this "ghost" company they are currently negotiating with.

I also agree with Paul about the FMI performance. Nortran is much further along in development than Forbes is, therefore I would expect to see Nortran gain a considerable value if the right deal is announced.

My guess is $5.00 plus by May 1/98
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext